Drug
Salbutamol Hfa 152a
Salbutamol Hfa 152a: highest development phase Phase 1, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| Salbutamol HFA-152a NCT06433921 | Phase 1 | Asthma |
Latest
No recent events.
Follow Salbutamol Hfa 152a on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.